Filing Details
- Accession Number:
- 0001127602-15-017644
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-05-18 16:13:47
- Reporting Period:
- 2015-05-15
- Filing Date:
- 2015-05-18
- Accepted Time:
- 2015-05-18 16:13:47
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1100682 | Charles River Laboratories International Inc | CRL | Services-Commercial Physical & Biological Research (8731) | 061397316 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1141720 | F Thomas Ackerman | 251 Ballardvale Street Wilmington MA 01887 | Corporate Executive Vp & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2015-05-15 | 100 | $70.94 | 101,635 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-05-15 | 200 | $70.95 | 101,435 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-05-15 | 200 | $70.96 | 101,235 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-05-15 | 100 | $70.97 | 101,135 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-05-15 | 100 | $71.03 | 101,035 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-05-15 | 100 | $71.10 | 100,935 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-05-15 | 100 | $71.17 | 100,835 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-05-15 | 100 | $71.26 | 100,735 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-05-15 | 100 | $71.39 | 100,635 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- This sale occurred pursuant to a 10b5-1 Trading Plan.